Cargando…
Individualised variable-interval risk-based screening for sight-threatening diabetic retinopathy: the Liverpool Risk Calculation Engine
AIMS/HYPOTHESIS: Individualised variable-interval risk-based screening offers better targeting and improved cost-effectiveness in screening for diabetic retinopathy. We developed a generalisable risk calculation engine (RCE) to assign personalised intervals linked to local population characteristics...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448900/ https://www.ncbi.nlm.nih.gov/pubmed/28840258 http://dx.doi.org/10.1007/s00125-017-4386-0 |
_version_ | 1783408747719163904 |
---|---|
author | Eleuteri, Antonio Fisher, Anthony C. Broadbent, Deborah M. García-Fiñana, Marta Cheyne, Christopher P. Wang, Amu Stratton, Irene M. Gabbay, Mark Seddon, Daniel Harding, Simon P. |
author_facet | Eleuteri, Antonio Fisher, Anthony C. Broadbent, Deborah M. García-Fiñana, Marta Cheyne, Christopher P. Wang, Amu Stratton, Irene M. Gabbay, Mark Seddon, Daniel Harding, Simon P. |
author_sort | Eleuteri, Antonio |
collection | PubMed |
description | AIMS/HYPOTHESIS: Individualised variable-interval risk-based screening offers better targeting and improved cost-effectiveness in screening for diabetic retinopathy. We developed a generalisable risk calculation engine (RCE) to assign personalised intervals linked to local population characteristics, and explored differences in assignment compared with current practice. METHODS: Data from 5 years of photographic screening and primary care for people with diabetes, screen negative at the first of > 1 episode, were combined in a purpose-built near-real-time warehouse. Covariates were selected from a dataset created using mixed qualitative/quantitative methods. Markov modelling predicted progression to screen-positive (referable diabetic retinopathy) against the local cohort history. Retinopathy grade informed baseline risk and multiple imputation dealt with missing data. Acceptable intervals (6, 12, 24 months) and risk threshold (2.5%) were established with patients and professional end users. RESULTS: Data were from 11,806 people with diabetes (46,525 episodes, 388 screen-positive). Covariates with sufficient predictive value were: duration of known disease, HbA(1c), age, systolic BP and total cholesterol. Corrected AUC (95% CIs) were: 6 months 0.88 (0.83, 0.93), 12 months 0.90 (0.87, 0.93) and 24 months 0.91 (0.87, 0.94). Sensitivities/specificities for a 2.5% risk were: 6 months 0.61, 0.93, 12 months 0.67, 0.90 and 24 months 0.82, 0.81. Implementing individualised RCE-based intervals would reduce the proportion of people becoming screen-positive before the allocated screening date by > 50% and the number of episodes by 30%. CONCLUSIONS/INTERPRETATION: The Liverpool RCE shows sufficient performance for a local introduction into practice before wider implementation, subject to external validation. This approach offers potential enhancements of screening in improved local applicability, targeting and cost-effectiveness. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00125-017-4386-0) contains peer-reviewed but unedited supplementary material, which is available to authorised users. |
format | Online Article Text |
id | pubmed-6448900 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-64489002019-04-17 Individualised variable-interval risk-based screening for sight-threatening diabetic retinopathy: the Liverpool Risk Calculation Engine Eleuteri, Antonio Fisher, Anthony C. Broadbent, Deborah M. García-Fiñana, Marta Cheyne, Christopher P. Wang, Amu Stratton, Irene M. Gabbay, Mark Seddon, Daniel Harding, Simon P. Diabetologia Article AIMS/HYPOTHESIS: Individualised variable-interval risk-based screening offers better targeting and improved cost-effectiveness in screening for diabetic retinopathy. We developed a generalisable risk calculation engine (RCE) to assign personalised intervals linked to local population characteristics, and explored differences in assignment compared with current practice. METHODS: Data from 5 years of photographic screening and primary care for people with diabetes, screen negative at the first of > 1 episode, were combined in a purpose-built near-real-time warehouse. Covariates were selected from a dataset created using mixed qualitative/quantitative methods. Markov modelling predicted progression to screen-positive (referable diabetic retinopathy) against the local cohort history. Retinopathy grade informed baseline risk and multiple imputation dealt with missing data. Acceptable intervals (6, 12, 24 months) and risk threshold (2.5%) were established with patients and professional end users. RESULTS: Data were from 11,806 people with diabetes (46,525 episodes, 388 screen-positive). Covariates with sufficient predictive value were: duration of known disease, HbA(1c), age, systolic BP and total cholesterol. Corrected AUC (95% CIs) were: 6 months 0.88 (0.83, 0.93), 12 months 0.90 (0.87, 0.93) and 24 months 0.91 (0.87, 0.94). Sensitivities/specificities for a 2.5% risk were: 6 months 0.61, 0.93, 12 months 0.67, 0.90 and 24 months 0.82, 0.81. Implementing individualised RCE-based intervals would reduce the proportion of people becoming screen-positive before the allocated screening date by > 50% and the number of episodes by 30%. CONCLUSIONS/INTERPRETATION: The Liverpool RCE shows sufficient performance for a local introduction into practice before wider implementation, subject to external validation. This approach offers potential enhancements of screening in improved local applicability, targeting and cost-effectiveness. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00125-017-4386-0) contains peer-reviewed but unedited supplementary material, which is available to authorised users. Springer Berlin Heidelberg 2017-08-24 2017 /pmc/articles/PMC6448900/ /pubmed/28840258 http://dx.doi.org/10.1007/s00125-017-4386-0 Text en © The Author(s) 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Article Eleuteri, Antonio Fisher, Anthony C. Broadbent, Deborah M. García-Fiñana, Marta Cheyne, Christopher P. Wang, Amu Stratton, Irene M. Gabbay, Mark Seddon, Daniel Harding, Simon P. Individualised variable-interval risk-based screening for sight-threatening diabetic retinopathy: the Liverpool Risk Calculation Engine |
title | Individualised variable-interval risk-based screening for sight-threatening diabetic retinopathy: the Liverpool Risk Calculation Engine |
title_full | Individualised variable-interval risk-based screening for sight-threatening diabetic retinopathy: the Liverpool Risk Calculation Engine |
title_fullStr | Individualised variable-interval risk-based screening for sight-threatening diabetic retinopathy: the Liverpool Risk Calculation Engine |
title_full_unstemmed | Individualised variable-interval risk-based screening for sight-threatening diabetic retinopathy: the Liverpool Risk Calculation Engine |
title_short | Individualised variable-interval risk-based screening for sight-threatening diabetic retinopathy: the Liverpool Risk Calculation Engine |
title_sort | individualised variable-interval risk-based screening for sight-threatening diabetic retinopathy: the liverpool risk calculation engine |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448900/ https://www.ncbi.nlm.nih.gov/pubmed/28840258 http://dx.doi.org/10.1007/s00125-017-4386-0 |
work_keys_str_mv | AT eleuteriantonio individualisedvariableintervalriskbasedscreeningforsightthreateningdiabeticretinopathytheliverpoolriskcalculationengine AT fisheranthonyc individualisedvariableintervalriskbasedscreeningforsightthreateningdiabeticretinopathytheliverpoolriskcalculationengine AT broadbentdeborahm individualisedvariableintervalriskbasedscreeningforsightthreateningdiabeticretinopathytheliverpoolriskcalculationengine AT garciafinanamarta individualisedvariableintervalriskbasedscreeningforsightthreateningdiabeticretinopathytheliverpoolriskcalculationengine AT cheynechristopherp individualisedvariableintervalriskbasedscreeningforsightthreateningdiabeticretinopathytheliverpoolriskcalculationengine AT wangamu individualisedvariableintervalriskbasedscreeningforsightthreateningdiabeticretinopathytheliverpoolriskcalculationengine AT strattonirenem individualisedvariableintervalriskbasedscreeningforsightthreateningdiabeticretinopathytheliverpoolriskcalculationengine AT gabbaymark individualisedvariableintervalriskbasedscreeningforsightthreateningdiabeticretinopathytheliverpoolriskcalculationengine AT seddondaniel individualisedvariableintervalriskbasedscreeningforsightthreateningdiabeticretinopathytheliverpoolriskcalculationengine AT hardingsimonp individualisedvariableintervalriskbasedscreeningforsightthreateningdiabeticretinopathytheliverpoolriskcalculationengine AT individualisedvariableintervalriskbasedscreeningforsightthreateningdiabeticretinopathytheliverpoolriskcalculationengine |